Click For Photo: https://i.dailymail.co.uk/1s/2019/07/20/16/16286262-0-image-a-17_1563636053247.jpgClick For Video: https://videos.dailymail.co.uk/video/mol/2018/04/24/3432994872095980788/1024x576_MP4_3432994872095980788.mp4
A breast cancer drug dubbed ‘magical’ by experts is now being made available to more NHS patients.
Ribociclib, also known by the brand name Kisqali, costs £35,000 a year and is one of a new class of targeted therapies that act on specific characteristics of tumours rather than the ‘carpet-bombing’ approach of chemotherapy, which destroys healthy cells too.
Drugs - Pill - Women - Type - Breast
It has been shown to help when other drugs have stopped working. The daily pill allows women with the most common type of advanced, incurable breast cancer to live longer, healthier lives by blocking an enzyme that helps tumour cells divide.
In April, the National Institute for Health and Care Excellence barred doctors from offering the drug to patients who were also being given an older, commonly prescribed breast cancer hormone drug, fulvestrant – to the anger of campaigners and doctors. But the watchdog has now reversed its decision, recognising that the combination of fulvestrant and ribociclib controlled the disease for an additional eight months, compared to fulvestrant alone.
Osteoarthritis - Researchers - University - East - Anglia
Could broccoli hold the secret to beating painful osteoarthritis? That’s what researchers at the University of East Anglia and Norfolk and Norwich Hospital aim to find out as part of a three-month trial that could see the humble vegetable become a mainstream treatment for the agonising condition, which affects 8.5 million people in the UK.
The Broccoli in Osteoarthritis trial follows...
Wake Up To Breaking News!
Merry Christmas! It's not just for December any longer!